Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
2012 ◽
Vol 7
(6)
◽
pp. 1032-1040
◽
Keyword(s):
Phase I
◽